-
- Tanaka Akihiko
- Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University, School of Medicine
この論文をさがす
抄録
The therapeutic history of asthma is divided into a period before and after the advent of inhaled corticosteroids (ICS). Before the advent of ICS, bronchodilators such as β2-agonists and anti-cholinergic agents were the main drugs used for asthma therapies. ICS were firstly launched in the market in 1978. Their effectiveness and safety have been recognized over time. Consequently, ICS were positioned as gold standard drugs for asthma therapy in the 1980s in Europe and North America and in the late 1990s in Japan. This review addresses the paradigm shift of the drug therapy for asthma.
収録刊行物
-
- Journal of General and Family Medicine
-
Journal of General and Family Medicine 16 (3), 158-169, 2015
一般社団法人 日本プライマリ・ケア連合学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205763294720
-
- NII論文ID
- 130005107501
-
- ISSN
- 21897948
- 21896577
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可